Procter & Gamble (NYSE:PG) PT Raised to $168.00 at Barclays

Procter & Gamble (NYSE:PG) had its price target hoisted by Barclays from $165.00 to $168.00 in a report published on Friday morning, Benzinga reports. The firm currently has an overweight rating on the stock.

PG has been the subject of a number of other research reports. Truist Financial raised Procter & Gamble from a hold rating to a buy rating and boosted their price target for the company from $160.00 to $175.00 in a research note on Monday, March 11th. Wells Fargo & Company increased their price target on Procter & Gamble from $162.00 to $170.00 and gave the stock an overweight rating in a report on Wednesday, January 24th. Royal Bank of Canada upped their target price on Procter & Gamble from $156.00 to $157.00 and gave the stock a sector perform rating in a research report on Wednesday, January 24th. Deutsche Bank Aktiengesellschaft increased their price target on Procter & Gamble from $170.00 to $172.00 and gave the company a buy rating in a research report on Wednesday, April 3rd. Finally, JPMorgan Chase & Co. decreased their target price on Procter & Gamble from $169.00 to $162.00 and set an overweight rating for the company in a research report on Thursday, January 18th. Seven investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average target price of $168.53.

Procter & Gamble Stock Performance

Shares of PG stock opened at $155.45 on Friday. The company has a quick ratio of 0.44, a current ratio of 0.64 and a debt-to-equity ratio of 0.48. The company’s fifty day simple moving average is $159.27 and its 200-day simple moving average is $152.70. Procter & Gamble has a 12 month low of $141.45 and a 12 month high of $163.14. The firm has a market cap of $365.78 billion, a PE ratio of 26.04, a P/E/G ratio of 3.18 and a beta of 0.44.

Procter & Gamble (NYSE:PG) last released its quarterly earnings data on Tuesday, January 23rd. The company reported $1.84 EPS for the quarter, beating the consensus estimate of $1.70 by $0.14. Procter & Gamble had a net margin of 17.60% and a return on equity of 34.04%. The firm had revenue of $21.44 billion for the quarter, compared to the consensus estimate of $21.48 billion. During the same period in the previous year, the company earned $1.59 earnings per share. The company’s quarterly revenue was up 3.2% on a year-over-year basis. Equities research analysts expect that Procter & Gamble will post 6.45 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a $1.0065 dividend. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.59%. Procter & Gamble’s dividend payout ratio is presently 62.98%.

Insiders Place Their Bets

In related news, CEO Gary A. Coombe sold 22,000 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the completion of the transaction, the chief executive officer now directly owns 36,845 shares of the company’s stock, valued at $5,943,835.40. The sale was disclosed in a filing with the SEC, which is available through this link. In other news, CEO Gary A. Coombe sold 22,000 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $161.32, for a total value of $3,549,040.00. Following the sale, the chief executive officer now directly owns 36,845 shares in the company, valued at $5,943,835.40. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Susan Street Whaley sold 3,865 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $160.60, for a total value of $620,719.00. Following the transaction, the insider now owns 11,886 shares in the company, valued at $1,908,891.60. The disclosure for this sale can be found here. Insiders sold a total of 279,063 shares of company stock worth $43,187,745 over the last quarter. 0.17% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Procter & Gamble

A number of institutional investors have recently modified their holdings of the stock. Advantage Trust Co purchased a new position in shares of Procter & Gamble during the fourth quarter worth $28,000. Naples Money Management LLC acquired a new stake in Procter & Gamble in the fourth quarter valued at $29,000. Wyrmwood Management LLC purchased a new position in shares of Procter & Gamble during the fourth quarter worth about $29,000. Transcendent Capital Group LLC purchased a new position in shares of Procter & Gamble during the fourth quarter worth about $31,000. Finally, MeadowBrook Investment Advisors LLC purchased a new position in shares of Procter & Gamble during the fourth quarter worth about $33,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.